Company: MIRA
Filing Date: 2025-08-08
Form Type: DEFM14A
Source: 0001641172-25-022816
Chunk: 23

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-08
Form: DEFM14A
Chunk 23
---
. For a summary of Moore’s fairness opinion and valuation report, please see page 27.

Immediately following the Merger, the pre-Merger equity holders of MIRA are expected to hold approximately 50% of the outstanding shares of MIRA Common Stock and the pre-Merger equity holders of SKNY are expected to hold approximately 50% of the outstanding shares of MIRA Common Stock. The Exchange Ratio is 1:1. Under the Merger Agreement, notwithstanding the relative values of MIRA and SKNY, in no instance shall SKNY receive an amount of MIRA Common Stock pursuant to the Merger in an amount greater than 50% of MIRA, as determined as of the date of the closing of the Merger.

For a more complete description of the Merger, the potential adjustments in the Exchange Ratio and the calculation of MIRA’s net cash, please see the section titled “ The Merger Agreement —Merger Consideration and Exchange Ratio.”

Treatment of SKNY Stock Options

SKNY currently has no stock options outstanding.

Treatment of SKNY Warrants

Under the terms of the Merger Agreement, the warrant to purchase shares of SKNY Common Stock that is outstanding will be converted into and become a warrant to purchase shares of MIRA Common Stock, and MIRA will assume each SKNY warrant in accordance with its terms.

Conditions to the Merger (see page 35)

The obligations to consummate the Merger and the other Contemplated Transactions are subject to the satisfaction or waiver, on or prior to the Effective Time, of the conditions set forth in the section entitled “ The Merger Agreement—Conditions to the Merger” below.

Termination (see page 35)

The Merger Agreement contains certain customary termination rights, including the right of either MIRA or SKNY to terminate the Merger Agreement if either company’s stockholders fail to adopt and approve the Merger Proposal, if the Closing has not occurred by December 31, 2025, if a governmental entity has issued a final ruling prohibiting the Closing, or by one party upon an uncured breach of the Merger Agreement. For a more complete description of the termination provisions, please see the section titled “ The Merger Agreement—Termination.”

Appraisal Rights and Dissenters’ Rights (see page 35)

Pursuant to Section 607.1302 of the Florida Business Corporation Act, the shareholders of MIRA will not be entitled to appraisal rights as a result of the Merger.

| 8